Electrophysiological effects of lorcainide in sinoatrial disease and in Wolff-Parkinson-White syndrome.
D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents; D044482:Benzeneacetamides; D002304:Cardiac Pacing, Artificial; D005260:Female; D006327:Heart Block / Q000503:physiopathology*; D006329:Heart Conduction System / Q000187:drug effects; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000494:pharmacology* / Q000627:therapeutic use; D012848:Sinoatrial Block / Q000188:drug therapy / Q000503:physiopathology*; D012849:Sinoatrial Node / Q000187:drug effects; D013997:Time Factors; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy / Q000503:physiopathology*
D000889:Anti-Arrhythmia Agents; D044482:Benzeneacetamides; D010880:Piperidines; C015970:lorcainide